- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Borosil Scientific has announced the results of its 34th Annual General Meeting. All resolutions put to shareholder vote were passed with significant majority. Shareholders approved the company's audited financial statements for the fiscal year ended March 31, 2025, and ratified key director re-appointments. Importantly, approval was granted for a material related party transaction with Borosil Limited, demonstrating continued operational ties. Furthermore, the company received shareholder consent to raise funds through the issuance of equity shares or other securities, providing flexibility for future growth and strategic initiatives. This reflects strong shareholder confidence in the company's direction.